Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $9.82 billion. The enterprise value is $10.09 billion.
Important Dates
The next estimated earnings date is Tuesday, February 4, 2025, after market close.
Earnings Date | Feb 4, 2025 |
Ex-Dividend Date | Dec 31, 2024 |
Share Statistics
Amdocs has 112.82 million shares outstanding. The number of shares has decreased by -3.63% in one year.
Current Share Class | 112.82M |
Shares Outstanding | 112.82M |
Shares Change (YoY) | -3.63% |
Shares Change (QoQ) | -1.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 99.10% |
Float | 112.63M |
Valuation Ratios
The trailing PE ratio is 20.49 and the forward PE ratio is 12.48. Amdocs's PEG ratio is 1.46.
PE Ratio | 20.49 |
Forward PE | 12.48 |
PS Ratio | 2.01 |
Forward PS | 2.15 |
PB Ratio | 2.84 |
P/TBV Ratio | 21.75 |
P/FCF Ratio | 15.86 |
P/OCF Ratio | 13.55 |
PEG Ratio | 1.46 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 10.59, with an EV/FCF ratio of 16.31.
EV / Earnings | 20.46 |
EV / Sales | 2.02 |
EV / EBITDA | 10.59 |
EV / EBIT | 13.28 |
EV / FCF | 16.31 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.20 |
Quick Ratio | 1.07 |
Debt / Equity | 0.23 |
Debt / EBITDA | 0.78 |
Debt / FCF | 1.28 |
Interest Coverage | 21.77 |
Financial Efficiency
Return on equity (ROE) is 14.05% and return on invested capital (ROIC) is 10.96%.
Return on Equity (ROE) | 14.05% |
Return on Assets (ROA) | 7.41% |
Return on Capital (ROIC) | 10.96% |
Revenue Per Employee | $163,056 |
Profits Per Employee | $16,068 |
Employee Count | 30,695 |
Asset Turnover | 0.78 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $94.75 million in taxes.
Income Tax | 94.75M |
Effective Tax Rate | 16.03% |
Stock Price Statistics
The stock price has decreased by -0.30% in the last 52 weeks. The beta is 0.72, so Amdocs's price volatility has been lower than the market average.
Beta (5Y) | 0.72 |
52-Week Price Change | -0.30% |
50-Day Moving Average | 87.95 |
200-Day Moving Average | 85.20 |
Relative Strength Index (RSI) | 49.81 |
Average Volume (20 Days) | 704,897 |
Short Selling Information
Short Interest | 3.28M |
Short Previous Month | 2.86M |
Short % of Shares Out | 3.29% |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.39 |
Income Statement
In the last 12 months, Amdocs had revenue of $5.00 billion and earned $493.20 million in profits. Earnings per share was $4.25.
Revenue | 5.00B |
Gross Profit | 1.76B |
Operating Income | 759.70M |
Pretax Income | 618.21M |
Net Income | 493.20M |
EBITDA | 952.76M |
EBIT | 759.70M |
Earnings Per Share (EPS) | $4.25 |
Full Income Statement Balance Sheet
The company has $514.33 million in cash and $789.74 million in debt, giving a net cash position of -$275.41 million or -$2.44 per share.
Cash & Cash Equivalents | 514.33M |
Total Debt | 789.74M |
Net Cash | -275.41M |
Net Cash Per Share | -$2.44 |
Equity (Book Value) | 3.50B |
Book Value Per Share | 30.62 |
Working Capital | 300.27M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $724.43 million and capital expenditures -$105.50 million, giving a free cash flow of $618.93 million.
Operating Cash Flow | 724.43M |
Capital Expenditures | -105.50M |
Free Cash Flow | 618.93M |
FCF Per Share | $5.49 |
Full Cash Flow Statement Margins
Gross margin is 35.07%, with operating and profit margins of 15.18% and 9.85%.
Gross Margin | 35.07% |
Operating Margin | 15.18% |
Pretax Margin | 11.81% |
Profit Margin | 9.85% |
EBITDA Margin | 19.04% |
EBIT Margin | 15.18% |
FCF Margin | 12.37% |
Dividends & Yields
This stock pays an annual dividend of $1.92, which amounts to a dividend yield of 2.20%.
Dividend Per Share | $1.92 |
Dividend Yield | 2.20% |
Dividend Growth (YoY) | 10.11% |
Years of Dividend Growth | n/a |
Payout Ratio | 45.12% |
Buyback Yield | 3.63% |
Shareholder Yield | 5.83% |
Earnings Yield | 5.02% |
FCF Yield | 6.31% |
Dividend Details Analyst Forecast
The average price target for Amdocs is $101.20, which is 16.31% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $101.20 |
Price Target Difference | 16.31% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Amdocs has an Altman Z-Score of 4.79 and a Piotroski F-Score of 5.
Altman Z-Score | 4.79 |
Piotroski F-Score | 5 |